These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1290070)

  • 21. [Toxoplasma infections in early pregnancy: consequences and management].
    Wallon M; Gaucherand P; Al Kurdi M; Peyron F
    J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):478-84. PubMed ID: 12379832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France.
    Gilbert RE; Gras L; Wallon M; Peyron F; Ades AE; Dunn DT
    Int J Epidemiol; 2001 Dec; 30(6):1303-8. PubMed ID: 11821334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congenital toxoplasmosis--prenatal aspects of Toxoplasma gondii infection.
    Rorman E; Zamir CS; Rilkis I; Ben-David H
    Reprod Toxicol; 2006 May; 21(4):458-72. PubMed ID: 16311017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis and therapy of congenital toxoplasmosis].
    Friese K; Weigel M; Melchert F
    Dtsch Med Wochenschr; 1993 Dec; 118(49):1814-6. PubMed ID: 8253045
    [No Abstract]   [Full Text] [Related]  

  • 25. Options for the pharmacotherapy of toxoplasmosis during pregnancy.
    Peyron F; Wallon M
    Expert Opin Pharmacother; 2001 Aug; 2(8):1269-74. PubMed ID: 11584994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Congenital toxoplasmosis: prevention in the pregnant woman and management of the neonate].
    Pelloux H; Fricker-Hidalgo H; Pons JC; Bost-Bru C; Brenier-Pinchart MP; Jouk PS; Ambroise-Thomas P
    Arch Pediatr; 2002 Feb; 9(2):206-12. PubMed ID: 11915504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis and therapy of toxoplasmosis infections in pregnancy at the Rostock University Gynecologic Clinic 1986-1994].
    Briese V; Rogmann K; Müller H; Plesse R
    Zentralbl Gynakol; 1995; 117(11):578-84. PubMed ID: 8533491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention and treatment of congenital toxoplasmosis.
    Petersen E
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):285-93. PubMed ID: 17402843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Toxoplasmosis in pregnancy: prevention, prenatal diagnosis and treatment].
    Hohlfeld P; Biedermann K; Extermann P; Gyr T
    Schweiz Med Wochenschr Suppl; 1995; 65():62S-69S. PubMed ID: 7716455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Toxoplasmosis and pregnancy: is it possible to simplify the diagnostic procedures?].
    Roth P; Maillet R; Dalphin ML; Schaal JP; Colette C
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(3):277-83. PubMed ID: 8345152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The prevalence of Toxoplasma gondii infection among 2016 pregnant women and their children in the Institute of Mother and Child in Warsaw].
    Niemiec KT; Raczyński P; Markiewicz K; Leibschang J; Ceran A
    Wiad Parazytol; 2002; 48(3):293-9. PubMed ID: 16888975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem?
    Eskild A; Oxman A; Magnus P; Bjørndal A; Bakketeig LS
    J Med Screen; 1996; 3(4):188-94. PubMed ID: 9041483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital toxoplasmosis from a mother with type 2 diabetes mellitus: a case report.
    Sato S; Nishida M; Nasu K; Narahara H; Norose K; Aosai F
    J Obstet Gynaecol Res; 2014 Nov; 40(11):2158-61. PubMed ID: 25164320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and management of toxoplasmosis.
    Montoya JG; Rosso F
    Clin Perinatol; 2005 Sep; 32(3):705-26. PubMed ID: 16085028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital toxoplasmosis.
    Olliaro P
    Clin Evid; 2004 Dec; (12):1058-61. PubMed ID: 15865702
    [No Abstract]   [Full Text] [Related]  

  • 36. Outcome of toxoplasmosis acquired during pregnancy following treatment in both pregnancy and early infancy.
    Galanakis E; Manoura A; Antoniou M; Sifakis S; Korakaki E; Hatzidaki E; Lambraki D; Tselentis Y; Giannakopoulou C
    Fetal Diagn Ther; 2007; 22(6):444-8. PubMed ID: 17652934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twenty-two years screening for toxoplasmosis in pregnancy: Liege-Belgium.
    Henri T; Jacques S; Rene L
    Scand J Infect Dis Suppl; 1992; 84():84-5. PubMed ID: 1290082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital toxoplasmosis: efficacy of maternal treatment with spiramycin alone.
    Vergani P; Ghidini A; Ceruti P; Strobelt N; Spelta A; Zapparoli B; Rescaldani R
    Am J Reprod Immunol; 1998 May; 39(5):335-40. PubMed ID: 9602252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fetomaternal therapeutic follow-up of spiramycin during pregnancy].
    Forestier F; Daffos F; Rainaut M; Desnottes JF; Gaschard JC
    Arch Fr Pediatr; 1987; 44(7):539-44. PubMed ID: 3426376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up].
    Ambroise-Thomas P; Schweitzer M; Pinon JM; Thiebaugeorges O
    Bull Acad Natl Med; 2001; 185(4):665-83; discussion 684-8. PubMed ID: 11503357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.